LARA TROISI: Open Payments
NPI 1528686185 · LIBERTY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,459 in 176 payments from 17 companies in 2025. Trend: 2023 $2,606 · 2024 $3,151 · 2025 $3,459
Food & beverage: $3,360Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $674 |
| Teva Pharmaceuticals USA, Inc. | 26 | $600 |
| Janssen Pharmaceuticals, Inc | 20 | $385 |
| Otsuka America Pharmaceutical, Inc. | 23 | $376 |
| Neurocrine BioSciences, Inc. | 11 | $276 |
| Axsome Therapeutics, Inc. | 11 | $165 |
| Supernus Pharmaceuticals, Inc. | 8 | $162 |
| Braeburn Inc. | 7 | $138 |
| Indivior Inc. | 9 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $129 |
Products named: VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, INGREZZA, REXULTI, ABILIFY ASIMTUFII, Auvelity, Qelbree.
Industry payments across NY — which companies pay providers there.
